Companies in #Infectious Disease

Anixa Biosciences is a clinical-stage biotechnology company developing vaccines and therapeutics for cancer and infectious disease. Lead programs include a breast cancer vaccine licensed from Cleveland Clinic and an ovarian cancer vaccine in collaboration with Moffitt Cancer Center.

Global mid-sized Contract Research Organization (CRO) operating in 23 countries, providing patient-centric clinical trial solutions for biopharma innovators across oncology, rare disease, and cell & gene therapy programs.

Innoviva Inc. (NASDAQ: INVA) is a specialty pharmaceutical company with a diversified portfolio of marketed therapeutics and a growing focus on long-acting drug delivery. The company is reviving the Lyndra Therapeutics long-acting oral drug platform, originally developed at Bob Langer's MIT lab, with Langer and Janet Woodcock as senior advisors.

RQ Bio is a UK-based biotechnology company developing a portfolio of virus-targeting monoclonal antibodies. The company emerged from research at the Rosalind Franklin Institute and raised a $115M Series A in 2026 to advance its preclinical pipeline of broadly neutralizing antibodies against viral pathogens.